Martin Meglasson
Overview
Martin Meglasson received an average of $761K in total compensation, including $293K in salary, at Bellerophon Therapeutics between 2014 and 2015. Martin Meglasson also received an average of $642K at Ligand Pharmaceuticals from 2006 to 2008.
- 2015
- 2014
- 2008
- 2007
- 2006
Bellerophon Therapeuticsformer Chief Scientific Officer
Bellerophon Therapeuticsformer Chief Scientific Officer
Ligand PharmaceuticalsVice President, Discovery Research
Ligand PharmaceuticalsVice President, Discovery Research
Ligand PharmaceuticalsVice President, Discovery Research
Source: SEC filings on April 27, 2016 and April 29, 2009.
Related executives
We found 15 more executives who work or worked at Bellerophon Therapeutics and Ligand Pharmaceuticals.
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
Charles Berkman
Ligand Pharmaceuticals
General Counsel
Fabian Tenenbaum
Bellerophon Therapeutics
Chief Executive Officer
Peter Fernandes
Bellerophon Therapeutics
Chief Regulatory and Safety Officer
Assaf Korner
Bellerophon Therapeutics
Chief Financial Officer
Deborah Quinn
Bellerophon Therapeutics